Fig. 3From: 18F-FDG PET/CT response in a phase 1/2 trial of nab-paclitaxel plus gemcitabine for advanced pancreatic cancerTime to best response by CT in the 125 and 100 mg/m2 nab-paclitaxel cohorts. CT, computed tomographyBack to article page